Clinical Trial Update: 89Zr-MMOT PET Imaging in Pancreatic and Ovarian Cancer Patients [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating 89Zr-MMOT PET imaging in pancreatic and ovarian cancer patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer
• Pancreatic Cancer

Snippet

Sponsor: University Medical Center Groningen | Conditions: Ovarian Neoplasms, Ovarian Diseases | Phase 1 | Status: COMPLETED